DepoMed CEO Arthur Higgins' 2019 pay rises 2% to $4.9M
DepoMed reports 2019 executive compensation
By ExecPay News
Published: April 20, 2020
DepoMed reported fiscal year 2019 executive compensation information on April 20, 2020.
In 2019, three DepoMed executives received on average a compensation package of $2.7M, a 42% increase compared to previous year.
Average pay of disclosed executives at DepoMed
Arthur J. Higgins, Chief Executive Officer, received $4.9M in total, which increased by 2% compared to 2018. 67% of Higgins' compensation, or $3.3M, was in stock awards. Higgins also received $793K in non-equity incentive plan, $800K in salary, as well as $9.1K in other compensation.
Stanley Bukofzer, Senior Vice President and Chief Scientific and Technical Officer, received a compensation package of $1.7M, which decreased by 23% compared to previous year. 55% of the compensation package, or $925K, was in stock awards.
Daniel A. Peisert, Chief Financial Officer, earned $1.6M in 2019, a 68% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 20, 2020.